As filed with the Securities and Exchange Commission on June 30, 2009



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________


FORM S-8


REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933

_______________


IGI Laboratories, Inc.

(Exact Name of Registrant as Specified in Its Charter)


Delaware

01-0355758

(State or Other Jurisdiction
of Incorporation or Operation)

(I.R.S. Employer Identification Number)


105 Lincoln Avenue

Buena, New Jersey 08310

(Address of Principal Executive Offices, including Zip Code)

__________________________________________

IGI Laboratories, Inc. 1998 Directors Stock Plan

IGI Laboratories Inc. 1999 Director Stock Option Plan

IGI Laboratories Inc. 1999 Stock Incentive Plan


(Full Title of the Plan)

___________________________________________

Philip Forte

105 Lincoln Avenue

Buena, New Jersey 08310

(Name, Address And Telephone Number, Including Area Code, of Agent For Service)

______________________________________________

Copies of communications to:

Brian Katz, Esq.

Pepper Hamilton LLP

3000 Two Logan Square

Eighteenth and Arch Streets

Philadelphia, PA 19103

(215) 981-4000

______________________________________________


Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (check one):


Large accelerated filer o

Accelerated filer o

 

 

Non-accelerated filer o

Smaller reporting company þ

(do not check if a smaller reporting company)

 


CALCULATION OF REGISTRATION FEE


Title of securities to be registered

Amount to be
registered (1)

Proposed maximum
offering price per share

Proposed maximum
aggregate offering  price

Amount of
registration fee

Common Stock ($0.01 par value)

1,700,000 (2)

$1.025 (4)

$1,742,500 (4)

$97.23

Common Stock ($0.01 par value)

1,815,500 (3)

$1.40 (4)

$2,541,700 (4)

$141.83

          Total

3,515,500

 

 

$239.06


(1)  Pursuant to Rule 416(b), there shall also be deemed covered hereby any additional securities that may hereinafter be offered or issued to prevent dilution resulting from stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations and similar transactions.


(2)  Consists of additional number of shares issuable under the IGI Laboratories, Inc. 1998 Directors Stock Plan and options to purchase shares of common stock issuable under the IGI Laboratories, Inc. 1999 Director Stock Option Plan.


(3)  Consists of shares purchasable upon exercise of options outstanding as of the date hereof to purchase common stock under the IGI Laboratories, Inc. 1999 Stock Incentive Plan.


(4)  Estimated solely for the purposes of calculating the registration fee in accordance with Rule 457(h)(1) and (c) under the Securities Act of 1933.   As to shares subject to outstanding but unexercised options, the price and fee are computed based upon the weighted average exercise price at which such options may be exercised.  As to the remaining shares, the price and fee were computed based upon $1.025 per share, the average of the high and low prices for the common stock reported on the NYSE Amex on June 26, 2009.






EXPLANATORY NOTE


Pursuant to General Instruction E of Form S-8, this Registration Statement is being filed to register 400,000 additional shares of IGI Laboratories, Inc.’s (the “Registrant’s”) common stock, par value $0.01 per share (the “Common Stock”), for issuance under the Registrant’s 1998 Directors Stock Plan (the “1998 Directors Stock Plan”). The contents of the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on November 19, 1998 (Reg. No. 333-67565) with respect to an aggregate of 200,000 shares of Common Stock issuable pursuant to the 1998 Directors Stock Plan is hereby incorporated by reference.


Pursuant to General Instruction E of Form S-8, this Registration Statement is also being filed to register 1,300,000 additional shares of the Registrant’s Common Stock for issuance under the Registrant’s 1999 Director Stock Option Plan (the “1999 Director Stock Option Plan”).  The contents of the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on December 20, 2000 (Reg. No. 333-52312) with respect to an aggregate of 675,000 shares of Common Stock issuable pursuant to the 1999 Director Stock Option Plan is hereby incorporated by reference.


Pursuant to General Instruction E of Form S-8, this Registration Statement is also being filed to register 1,815,500 additional shares of the Registrant’s Common Stock for issuance under the Registrant’s 1999 Stock Incentive Plan (the “1999 Stock Incentive Plan”).  The contents of the Registrant’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on May 26, 1999 (Reg. No. 333-79333) with respect to an aggregate of 1,200,000 shares of Common Stock issuable pursuant to the 1999 Stock Incentive Plan is hereby incorporated by reference.


Item 8.  Exhibits.


4.1*

IGI Laboratories, Inc. 1998 Directors Stock Plan

 

 

4.2*

IGI Laboratories Inc. 1999 Director Stock Option Plan

 

 

4.3*

IGI Laboratories Inc. 1999 Stock Incentive Plan

 

 

5.1*

Opinion of Pepper Hamilton LLP as to the validity of the securities being registered.

 

 

23.1*

Consent of Amper, Politziner & Mattia, LLP

 

 

23.2

Consent of Pepper Hamilton LLP (included in Exhibit 5.1 hereto).

 

 

24.1

Powers of Attorney (included on the signature page hereto).


_____________

* Filed herewith.







SIGNATURES


Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Buena, New Jersey, on
June 30, 2009.


 

IGI Laboratories, Inc.

 

 

 

By:

/s/ Hemanshu Pandya

 

Hemanshu Pandya

 

President and Chief Executive Officer


POWER OF ATTORNEY


Each person whose signature appears below hereby constitutes and appoints Joyce Erony and Philip Forte his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for him in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto such attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that such attorney-in-fact and agent or his substitutes may do or cause to be done by virtue hereof.


Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on June 30, 2009:


Signature

 

Title

/s/ Hemanshu Pandya

 

President and Chief Executive Officer
(Principal Executive Officer)

Hemanshu Pandya

 

 

 

 

/s/ Philip Forte

 

Controller  (Principal Financial and Accounting Officer)

Philip Forte

 

 

 

 

 

/s/ Joyce Erony

 

Director

Joyce Erony

 

 

 

 

 

/s/ Stephen J. Morris

 

Director

Stephen J. Morris

 

 

 

 

 

/s/ Terrence O’Donnell

 

Director

Terrence O’Donnell

 

 

 

 

 

/s/ Jane E. Hager

 

Director

Jane E. Hager

 

 

 

 

 

/s/ James C. Gale

 

Director

James C. Gale

 

 








EXHIBIT INDEX


Exhibits


4.1*

IGI Laboratories, Inc. 1998 Directors Stock Plan

 

 

4.2*

IGI Laboratories Inc. 1999 Director Stock Option Plan

 

 

4.3*

IGI Laboratories Inc. 1999 Stock Incentive Plan

 

 

5.1*

Opinion of Pepper Hamilton LLP as to the validity of the securities being registered.

 

 

23.1*

Consent of Amper, Politziner & Mattia, LLP

 

 

23.2

Consent of Pepper Hamilton LLP (included in Exhibit 5.1 hereto).

 

 

24.1

Powers of Attorney (included on the signature page hereto).


_____________

* Filed herewith.







Exhibit 4.1


IGI LABORATORIES, INC.


1998 DIRECTORS STOCK PLAN, AS AMENDED


1.

Purpose.

The purpose of the 1998 Directors Stock Plan (the “Plan”) of IGI Laboratories, Inc. (the “Company”) is to provide for the payment of fees to the outside (non-employee) Directors of the Company in Common Stock of the Company in lieu of cash and thereby encourage ownership in the Company by the Directors.

2.

Participation in the Plan.

Directors of the Company who are not employees of the Company or any subsidiary of the Company shall be eligible to participate in the Plan.

3.

Stock Subject to the Plan.

The shares issuable under the Plan shall consist of 600,000 shares of the Company's Common Stock, $.01 par value per share (the “Common Stock”), subject to adjustment in the event of stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations and similar transactions.

4.

Issuance of Common Stock in Lieu of Payment of Directors Fees in Cash.

a)

Attached to the Plan as Appendix A is a schedule setting forth the fees payable (as of the date of adoption of the Plan) to outside Directors for their services as Directors, including fees payable for attendance at Directors meetings (both regular and telephonic) and committee meetings. If and when the fees payable to Directors are revised by action of the Board of Directors of the Company, the new fees shall be set forth in a schedule and annexed to the Plan as amended Appendix A and shall govern the payment of fees to Directors until any subsequent revisions are adopted by the Board of Directors.

b)

The total fees payable to the outside Directors for each calendar quarter shall be determined on the basis of the cash fees set forth in Appendix A. As soon as practicable after the end of each calendar quarter, the Company shall issue to each outside Director that number of shares of Common Stock as shall be determined by dividing

i.

the total dollar amount of fees payable to the Directors for the applicable quarter by

ii.

the closing per share price of the Common stock on the American Stock Exchange on the last day of the applicable quarter.







c)

The shares of Common Stock will be issued in the name of each outside Director and the certificate for such shares shall be delivered to the Directors as soon as practicable after the end of each calendar quarter, together with a notification from the Company containing the information set forth in Appendix B annexed hereto.

d)

The Company plans to register the Common Stock covered by the Plan under the Securities Act of 1933 (the “Act”) on Form S-8; but notwithstanding such registration, Directors serving as members of the Board at the time they wish to sell Common Stock received by them under the Plan shall be subject to the volume and other limitations contained in Rule 144 promulgated under the Act.

e)

The shares of Common Stock received by Directors pursuant to the Plan shall be deemed to be compensation for services and therefore subject to ordinary income taxes and will be reported to the Internal Revenue Service on Form 1099 or such other appropriate Internal Revenue Service form.

f)

The rights and benefits under the Plan are expressly provided to substitute Common Stock for cash payment of Directors fees, and the Plan shall be in addition to any other rights and benefits to which the Directors are entitled under any other plans of the Company, including any stock option plan for Directors currently in effect or adopted in the future.

5.

The Effective Date and Duration of the Plan.


a)

The Plan shall become effective when adopted by the Board of Directors and shall also apply to any past Directors fees earned by Directors which were unpaid by the Company at the time that the Plan was so adopted by the Board.


b)

The Plan shall continue to apply to all fees earned by Directors from and after the date of its adoption by the Board of Directors until terminated by action of the Board of Directors or otherwise amended by the Board of Directors.


6.

Governing Law.


The Plan shall be governed by the laws of the State of Delaware.


Approved by the Board of Directors of IGI on October 19, 1998.







APPENDIX A


SCHEDULE OF DIRECTORS FEES


The following sets forth the amount of fees payable to outside Directors of IGI Laboratories, Inc. for their services as Directors:

Event

Fee

Scheduled Directors Meeting

$2,000

Telephonic Directors Meeting

$1,000

Committee Meeting Held on Same Day as
Directors Meeting

$500

Committee Meeting Not Held on Same Day as
Directors Meeting

$1,000

Annual Fee for Chairman of the Audit
Committee (1)

$5,000

Annual Fee for Chairman of the Compensation
Committee (1)

$4,000

Annual Fee for Chairman of a Special
Committee (1)

$4,000


(1) Such amount is payable at the discretion of the board of directors.





Exhibit 4.2

IGI, INC.

1999 DIRECTOR STOCK OPTION PLAN, AS AMENDED


1.

Purpose


The purpose of this 1999 Director Stock Option Plan (the “Plan”) of IGI, Inc. (the “Company”) is to encourage ownership in the Company by outside directors of the Company whose continued services are considered essential to the Company’s future progress and to provide them with a further incentive to remain as directors of the Company.


2.

Administration


The Board of Directors shall supervise and administer the Plan. Grants of stock options under the Plan and the amount and nature of the awards to be granted shall be automatic in accordance with Section 5. However, all questions of interpretation of the Plan or of any options issued under it shall be determined by the Board of Directors and such determination shall be final and binding upon all persons having an interest in the Plan.


3.

Participation in the Plan


Directors of the Company who are not employees of the Company or any subsidiary of the Company shall be eligible to participate in the Plan.


4.

Stock Subject to the Plan


(a)

The maximum number of shares which may be issued under the Plan shall be 1,975,000 shares of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”), subject to adjustment as provided in Section 9 of the Plan.


(b)

If any outstanding option under the Plan for any reason expires or is terminated without having been exercised in full, the shares allocable to the unexercised portion of such option shall again become available for grant pursuant to the Plan.


(c)

All options granted under the Plan shall be non-statutory options not entitled to special tax treatment under Section 422 of the Internal Revenue Code of 1986, as amended to date and as it may be amended from time to time (the “Code”).


5.

Terms, Conditions and Form of Options


Each option granted under the Plan shall be evidenced by a written agreement in such form as the Board of Directors shall from time to time approve, which agreements shall comply with and be subject to the following terms and conditions:




(a)

Option Grant Dates .


(1)

On September 15, 1999, the Company shall grant to each eligible director an option to purchase 50,000 shares of Common Stock in consideration for past services performed.


(2)

Each year on January 2, beginning with January 2, 2000, the Company shall grant to each eligible director an option to purchase 15,000 shares of Common Stock (the “Annual Grant”).


(3)

Each year on January 2, beginning with January 2, 2000, the Company shall grant to the Chairman of the Audit Committee an option to purchase 15,000 shares of Common Stock, and to the Chairman of the Stock Option and Compensation Committee an option to purchase 10,000 shares of Common Stock.


(4)

Upon the initial election of any eligible director as a director of the Company, the Company shall grant to such director an option to purchase 15,000 shares of Common Stock (the “Initial Option”), provided that no person serving as a director on September 15, 1999 shall receive such an option.


(b)

Option Exercise Price .  The option exercise price per share for each option granted under the Plan shall equal the fair market value per share on the date of grant, which is deemed to be the closing price of the Common Stock on the American Stock Exchange on the date of grant. If the Common Stock is not then traded on the American Stock Exchange, the fair market value shall be determined in good faith by the Board of Directors.


(c)

Options Non-Transferable .  Except as otherwise provided in the option agreement evidencing the option grant, each option granted under the Plan shall not be transferable by the optionee otherwise than by will, or by the laws of descent and distribution, and shall be exercised during the lifetime of the optionee only by the optionee.


(d)

Exercise Period .  Each option granted under the Plan shall become exercisable in full, 12 months after the date of grant.


(e)

Exercise Procedure .  Options may be exercised only by written notice to the Company at its principal office accompanied by (i) payment in cash of the full consideration for the shares as to which they are exercised or (ii) an irrevocable undertaking by a broker to deliver promptly to the Company sufficient funds to pay the exercise price or delivery of irrevocable instructions to a broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price.


6.

Assignments


The rights and benefits of participants under the Plan may not be assigned, whether voluntarily or by operation of law, except as provided in Section 5(c).




-2-



7.

Effective Date


The Plan shall become effective September 15, 1999.


8.

Limitation of Rights


(a)

No Right to Continue as a Director .  Neither the Plan, nor the granting of an option nor any other action taken pursuant to the Plan, shall constitute or be evidence of any agreement or understanding, express or implied, that the Company will retain a director for any period of time.


(b)

No Stockholders’ Rights for Options .


An optionee shall have no rights as a stockholder with respect to the shares covered by his options until the date of the issuance to him of a stock certificate therefor, and no adjustment will be made for dividends or other rights (except as provided in Section 9) for which the record date is prior to the date such certificate is issued.


9.

Changes in Common Stock


(a)

If the outstanding shares of Common Stock are increased, decreased or exchanged for a different number or kind of shares or other securities, or if additional shares or new or different shares or other securities are distributed with respect to such shares of Common Stock or other securities, through a merger, consolidation, sale of all or substantially all of the assets of the Company, reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other distribution with respect to such shares of Common Stock, or other securities, an appropriate and proportionate adjustment will be made in (i) the maximum number and kind of shares reserved for issuance under the Plan, (ii) the number and kind of shares or other securities subject to then outstanding options under the Plan and (iii) the price for each share subject to any then outstanding options under the Plan, without changing the aggregate purchase price as to which such options remain exercisable. No fractional shares will be issued under the Plan on account of any such adjustments.


(b)

In the event that the Company is merged or consolidated into or with another corporation (in which consolidation or merger the stockholders of the Company receive distributions of cash or securities of another issuer as a result thereof), or in the event that all or substantially all of the assets of the Company are acquired by any other person or entity, or in the event of a reorganization or liquidation of the Company, then (i) all outstanding options shall automatically become vested in full and fully exercisable immediately prior to the consummation of such merger, consolidation, acquisition, reorganization or liquidation, and (ii) the Board of Directors of the Company, or the board of directors of any corporation assuming the obligations of the Company, shall, as to outstanding options, either (x) provide that such options shall be assumed, or equivalent options shall be substituted, by the acquiring or successor corporation (or affiliate thereof), or (y) upon written notice to the optionees, provide that all unexercised options will terminate immediately following the vesting of such options in accordance with clause (i)



-3-


above and immediately prior to the consummation of such merger, consolidation, acquisition, reorganization or liquidation unless exercised by the optionee within a specified number of days following the date of such notice.


10.

Amendment of the Plan


The Board of Directors may at any time, and from time to time, modify, terminate or amend the Plan in any respect, except that if at any time the approval of the stockholders of the Company is required as to such modification or amendment under any applicable listing requirement or any applicable tax or regulatory requirement, the Board of Directors may not effect such modification or amendment without such approval.


11.

Notice


Any written notice to the Company required by any of the provisions of the Plan shall be addressed to the Controller of the Company and shall become effective when it is received.


12.

Governing Law


The Plan and all determinations made and actions taken pursuant hereto shall be governed by the laws of the State of Delaware.




-4-


Exhibit 4.3


IGI, INC.

1999 STOCK INCENTIVE PLAN, AS AMENDED


1.

Purpose


The purpose of this 1999 Stock Incentive Plan (the “Plan”) of IGI, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing such persons with equity ownership opportunities and performance-based incentives and thereby better aligning the interests of such persons with those of the Company’s stockholders.  Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future subsidiary corporations as defined in Section 424(f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the Company has a significant interest, as determined by the Board of Directors of the Company (the “Board”).


2.

Eligibility


All of the Company’s employees, officers, directors, consultants and advisors (and any individuals who have accepted an offer for employment) are eligible to be granted options or restricted stock awards (each, an “Award”) under the Plan.  Each person who has been granted an Award under the Plan shall be deemed a “Participant.”


3.

Administration, Delegation


(a)

Administration by Board of Directors .  The Plan will be administered by the Board.  The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the Plan as it shall deem advisable.  The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry the Plan into effect and it shall be the sole and final judge of such expediency.  All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan or in any Award.  No director or person acting pursuant to the authority delegated by the Board shall be liable for any action or determination relating to or under the Plan made in good faith.


(b)

Delegation to Executive Officers .  To the extent permitted by applicable law, the Board may delegate to one or more executive officers of the Company the power to make Awards and exercise such other powers under the Plan as the Board may determine, provided that the Board shall fix the maximum number of shares subject to Awards and the maximum number of shares for any one Participant to be made by such executive officers.




(c)

Appointment of Committees .  To the extent permitted by applicable law, the Board may delegate any or all of its powers under the Plan to one or more committees or subcommittees of the Board (a “Committee”).  All references in the Plan to the “Board” shall mean the Board or a Committee of the Board or the executive officer referred to in Section 3(b) to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee or executive officer.


4.

Stock Available for Awards


(a)

Number of Shares .  Subject to adjustment under Section 7, Awards may be made under the Plan for up to 3,200,000 shares of common stock, $.01 par value per share, of the Company (the “Common Stock”).  If any Award expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available for the grant of Awards under the Plan, subject, however, in the case of Incentive Stock Options (as hereinafter defined), to any limitation required under the Code.  Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares.


(b)

Per-Participant Limit .  Subject to adjustment under Section 7, the maximum number of shares of Common Stock with respect to which an Award may be granted to any Participant under the Plan shall be 300,000 per calendar year.  The per-Participant limit described in this Section 4(b) shall be construed and applied consistently with Section 162(m) of the Code.


5.

Stock Options


(a)

General .  The Board may grant options to purchase Common Stock (each, an “Option”) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable.  An Option which is not intended to be an Incentive Stock Option (as hereinafter defined) shall be designated a “Nonstatutory Stock Option.”


(b)

Incentive Stock Options .  An Option that the Board intends to be an “incentive stock option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of the Company and shall be subject to and shall be construed consistently with the requirements of Section 422 of the Code.


The Company shall have no liability to a Participant, or any other party, if an Option (or any part thereof) which is intended to be an Incentive Stock Option is not an Incentive Stock Option.


(c)

Exercise Price .  The Board shall establish the exercise price at the time each Option is granted and specify it in the applicable option agreement.




-2-


(d)

Duration of Options .  Each Option shall be exercisable at such times and subject to such terms and conditions as the Board may specify in the applicable option agreement; provided, however, that no Option will be granted for a term in excess of 10 years.


(e)

Exercise of Option .  Options may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in Section 5(f) for the number of shares for which the Option is exercised.


(f)

Payment Upon Exercise .  Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as follows:


(1)

in cash or by check, payable to the order of the Company;


(2)

except as the Board may, in its sole discretion, otherwise provide in an option agreement, by (i) delivery of an irrevocable and unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price;


(3)

when the Common Stock is registered under the Exchange Act, by delivery of shares of Common Stock owned by the Participant valued at their fair market value as determined by (or in a manner approved by) the Board in good faith (“Fair Market Value”), provided (i) such method of payment is then permitted under applicable law and (ii) such Common Stock was owned by the Participant at least six months prior to such delivery;


(4)

to the extent permitted by the Board, in its sole discretion by (i) delivery of a promissory note of the Participant to the Company on terms determined by the Board, or (ii) payment of such other lawful consideration as the Board may determine; or


(5)

by any combination of the above permitted forms of payment.


6.

Restricted Stock


(a)

Grants .  The Board may grant Awards entitling recipients to acquire shares of Common Stock, subject to the right of the Company to repurchase all or part of such shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the end of the applicable restriction period or periods established by the Board for such Award (each, a “Restricted Stock Award”).


(b)

Terms and Conditions .  The Board shall determine the terms and conditions of any such Restricted Stock Award, including the conditions for repurchase (or forfeiture) and the issue price, if any.  Any stock certificates issued in respect of a Restricted Stock Award shall be registered in the name of the Participant and, unless otherwise determined by the Board,



-3-


deposited by the Participant, together with a stock power endorsed in blank, with the Company (or its designee).  At the expiration of the applicable restriction periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to receive amounts due or exercise rights of the Participant in the event of the Participant’s death (the “Designated Beneficiary”).  In the absence of an effective designation by a Participant, Designated Beneficiary shall mean the Participant’s estate.


7.

Adjustments for Changes in Common Stock and Certain Other Events


(a)

Changes in Capitalization .  In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any distribution to holders of Common Stock other than a normal cash dividend, (i) the number and class of securities available under this Plan, (ii) the per-Participant limit set forth in Section 4(b), (iii) the number and class of securities and exercise price per share subject to each outstanding Option, (iv) the repurchase price per share subject to each outstanding Restricted Stock Award, and (v) the terms of each other outstanding Award shall be appropriately adjusted by the Company (or substituted Awards may be made, if applicable) to the extent the Board shall determine, in good faith, that such an adjustment (or substitution) is necessary and appropriate.  If this Section 7(a) applies and Section 7(c) also applies to any event, Section 7(c) shall be applicable to such event, and this Section 7(a) shall not be applicable.


(b)

Liquidation or Dissolution .  In the event of a proposed liquidation or dissolution of the Company, the Board shall upon written notice to the Participants provide that all then unexercised Options will (i) become exercisable in full as of a specified time at least 10 business days prior to the effective date of such liquidation or dissolution and (ii) terminate effective upon such liquidation or dissolution, except to the extent exercised before such effective date.  The Board may specify the effect of a liquidation or dissolution on any Restricted Stock Award or other Award granted under the Plan at the time of the grant of such Award.


(c)

Acquisition Events .


(1)

Definition .  An “Acquisition Event” shall mean:  (a) any merger or consolidation of the Company with or into another entity as a result of which the Common Stock is converted into or exchanged for the right to receive cash, securities or other property or (b) any exchange of shares of the Company for cash, securities or other property pursuant to a statutory share exchange transaction.


(2)

Consequences of an Acquisition Event on Options .  Upon the occurrence of an Acquisition Event, or the execution by the Company of any agreement with respect to an Acquisition Event, the Board shall provide that all outstanding Options shall be assumed, or equivalent options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof).  For purposes hereof, an Option shall be considered to be assumed if, following consummation of the Acquisition Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the consummation of the



-4-


Acquisition Event, the consideration (whether cash, securities or other property) received as a result of the Acquisition Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Acquisition Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration received as a result of the Acquisition Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) equivalent in fair market value to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Acquisition Event.


Notwithstanding the foregoing, if the acquiring or succeeding corporation (or an affiliate thereof) does not agree to assume, or substitute for, such Options, then the Board shall, upon written notice to the Participants, provide that all then unexercised Options will become exercisable in full as of a specified time prior to the Acquisition Event and will terminate immediately prior to the consummation of such Acquisition Event, except to the extent exercised by the Participants before the consummation of such Acquisition Event; provided, however, that in the event of an Acquisition Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share of Common Stock surrendered pursuant to such Acquisition Event (the “Acquisition Price”), then the Board may instead provide that all outstanding Options shall terminate upon consummation of such Acquisition Event and that each Participant shall receive, in exchange therefor, a cash payment equal to the amount (if any) by which (A) the Acquisition Price multiplied by the number of shares of Common Stock subject to such outstanding Options (whether or not then exercisable), exceeds (B) the aggregate exercise price of such Options.


(3)

Consequences of an Acquisition Event on Restricted Stock Awards.  Upon the occurrence of an Acquisition Event, the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor and shall apply to the cash, securities or other property which the Common Stock was converted into or exchanged for pursuant to such Acquisition Event in the same manner and to the same extent as they applied to the Common Stock subject to such Restricted Stock Award.


8.

General Provisions Applicable to Awards


(a)

Transferability of Awards.  Except as the Board may otherwise determine or provide in an Award, Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the life of the Participant, shall be exercisable only by the Participant.  References to a Participant, to the extent relevant in the context, shall include references to authorized transferees.


(b)

Documentation .  Each Award shall be evidenced by a written instrument in such form as the Board shall determine.  Such written instrument may be in the form of an agreement signed by the Company and the Participant or a written confirming memorandum to the



-5-


Participant from the Company.  Each Award may contain terms and conditions in addition to those set forth in the Plan.


(c)

Board Discretion .  Except as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award.  The terms of each Award need not be identical, and the Board need not treat Participants uniformly.


(d)

Termination of Status .  The Board shall determine the effect on an Award of the disability, death, retirement, authorized leave of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, the Participant’s legal representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award.


(e)

Withholding .  Each Participant shall pay to the Company, or make provision satisfactory to the Board for payment of, any taxes required by law to be withheld in connection with Awards to such Participant no later than the date of the event creating the tax liability.  Except as the Board may otherwise provide in an Award, Participants may, to the extent then permitted under applicable law, satisfy such tax obligations in whole or in part by delivery of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value.  The Company may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to a Participant.


(f)

Amendment of Award .  The Board may amend, modify or terminate any outstanding Award, including but not limited to, substituting therefor another Award of the same or a different type, changing the date of exercise or realization, and converting an Incentive Stock Option to a Nonstatutory Stock Option, provided that the Participant’s consent to such action shall be required unless the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant.


(g)

Conditions on Delivery of Stock .  The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s counsel, all other legal matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations.


(h)

Acceleration .  The Board may at any time provide that any Options shall become immediately exercisable in full or in part, that any Restricted Stock Awards shall be free of restrictions in full or in part or that any other Awards may become exercisable in full or in part or free of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be.




-6-


9.

Miscellaneous


(a)

No Right To Employment or Other Status .  No person shall have any claim or right to be granted an Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the Company.  The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award.


(b)

No Rights As Stockholder .  Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares.  Notwithstanding the foregoing, in the event the Company effects a split of the Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to such Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend.


(c)

Effective Date and Term of Plan .  The Plan shall become effective on the date on which it is adopted by the Board, but no Award granted to a Participant designated by the Board as subject to Section 162(m) of the Code by the Board shall become exercisable, vested or realizable, as applicable to such Award, unless and until the Plan has been approved by the Company’s stockholders to the extent stockholder approval is required by Section 162(m) in the manner required under Section 162(m) (including the vote required under Section 162(m)).  No Awards shall be granted under the Plan after the completion of ten years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously granted may extend beyond that date.


(d)

Amendment of Plan .  The Board may amend, suspend or terminate the Plan or any portion thereof at any time, provided that to the extent required by Section 162(m) of the Code, no Award granted to a Participant designated as subject to Section 162(m) by the Board after the date of such amendment shall become exercisable, realizable or vested, as applicable to such Award (to the extent that such amendment to the Plan was required to grant such Award to a particular Participant), unless and until such amendment shall have been approved by the Company’s stockholders as required by Section 162(m) (including the vote required under Section 162(m)).


(e)

Governing Law .  The provisions of the Plan and all Awards made hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, without regard to any applicable conflicts of law.




-7-


Exhibit 5.1


[D72375_EX51002.GIF]


3000 Two Logan Square

Eighteenth and Arch Streets

Philadelphia, PA  19103-2799

215.981.4000

Fax 215.981.4750


June 30, 2009



IGI Laboratories, Inc.

105 Lincoln Avenue

Buena, New Jersey 08310


Re:

Registration Statement on Form S-8


Ladies and Gentlemen:


Reference is made to the registration statement on Form S-8 (the “Registration Statement”) of IGI Laboratories, Inc., a Delaware corporation (the “Company”), filed on the date hereof with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”). The Registration Statement covers up to 3,515,500 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), 400,000 of which may be issued by the Company pursuant to the IGI Laboratories Inc. 1998 Directors Stock Plan (the “Directors Stock Plan”), 1,300,000 of which may be issued by the Company pursuant to the IGI Laboratories Inc. 1999 Director Stock Option Plan (the “Director Stock Option Plan”) and 1,815,500 of which may be issued by the Company pursuant to the IGI Laboratories Inc. 1999 Stock Incentive Plan (the “1999 Stock Incentive Plan”, and together with the Directors Stock Plan and the Director Stock Option Plan, the “Plans”).


We have examined the Registration Statement, including the exhibits thereto, the originals or copies, certified or otherwise identified to our satisfaction, of the Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws of the Company, each as amended to date, the Plans, and such other documents as we have deemed appropriate in rendering this opinion. As to matters of fact, we have relied on representations of officers of the Company. In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the authenticity of all documents submitted to us as copies of originals.


Based on the foregoing, we are of the opinion that the Shares, when issued in accordance with the terms of the Plans, will be legally issued, fully paid and non-assessable. This opinion is being furnished to you solely for submission to the Commission as an exhibit to the Registration Statement and, accordingly, may not be relied upon, quoted in any manner to, or delivered to any other person or entity, without in each instance our prior written consent.


Our opinion is limited to the Delaware General Corporation Law and the federal securities laws, each as in effect as of the date hereof.   We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.




We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the Commission thereunder.


 

/s/ PEPPER HAMILTON LLP

PEPPER HAMILTON LLP






Exhibit 23.1


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors and Stockholders

IGI Laboratories, Inc. and Subsidiaries

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of IGI Laboratories, Inc. and Subsidiaries of our report dated March 31, 2009, appearing in the 2008 Annual Report on Form 10-K of IGI Laboratories, Inc. and Subsidiaries.



/s/ Amper, Politziner & Mattia, LLP


Edison, New Jersey

June 30, 2009